ARTG 429310BlastGen / EmbryoGen - In vitro fertilization culture medium kit
ARTG ID: 429310 · Origio Australasia Pty Ltd · Origio A/S · Class III · Started November 30, 2023
Good Name: Origio Australasia Pty Ltd - BlastGen / EmbryoGen - In vitro fertilization culture medium kit
- Risk Class
- Class III
- Product Type
- Procedure Pack
- ARTG Category
- General
- ARTG ID
- 429310
- Start Date
- November 30, 2023
- Effective Date
- November 30, 2023
- Name
- Origio A/S
- Country
- Denmark
- Address
- Knardrupvej 2, Malov, DK-2760
BlastGen™ is for the culture of 4-8 cell stage human embryos to the blastocyst stage. BlastGen™ may also be used for embryo transfer. EmbryoGen® is for the culture of human embryos until the 2-8 cell stage. EmbryoGen® can also be used for embryo transfer on Day 2 or Day 3.
Access comprehensive regulatory information for BlastGen / EmbryoGen - In vitro fertilization culture medium kit in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 429310 and sponsored by Origio Australasia Pty Ltd, manufactured by Origio A/S in Denmark. The device registration started on November 30, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.